| Eric Duffey Graham, MD | |
|
604 N. Spring Street, Harrison, AR 72601-2952 | |
| (870) 741-6418 | |
| (870) 741-5071 |
| Full Name | Eric Duffey Graham |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 19 Years |
| Location | 604 N. Spring Street, Harrison, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639397383 | NPI | - | NPPES |
| 192759001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | N6879 (Texas) | Primary |
| 208600000X | Surgery | E-7458 (Arkansas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Arkansas Regional Medical Center | Harrison, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Arkansas Regional Medical Center | 5193615896 | 60 |
News Archive
Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus University Hospital, and Rigshospitalet.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
University of Central Florida researchers have shown for the first time that light energy can gently guide and change the orientation of living cells within lab cultures. That ability to optically steer cells could be a major step in harnessing the healing power of stem cells and guiding them to areas of the body that need help.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
› Verified 3 days ago
| Entity Name | North Arkansas Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003180035 PECOS PAC ID: 5193615896 Enrollment ID: O20120716000496 |
News Archive
Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus University Hospital, and Rigshospitalet.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
University of Central Florida researchers have shown for the first time that light energy can gently guide and change the orientation of living cells within lab cultures. That ability to optically steer cells could be a major step in harnessing the healing power of stem cells and guiding them to areas of the body that need help.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Duffey Graham, MD 604 N. Spring Street, Harrison, AR 72601-2952 Ph: (870) 741-6418 | Eric Duffey Graham, MD 604 N. Spring Street, Harrison, AR 72601-2952 Ph: (870) 741-6418 |
News Archive
Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus University Hospital, and Rigshospitalet.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
University of Central Florida researchers have shown for the first time that light energy can gently guide and change the orientation of living cells within lab cultures. That ability to optically steer cells could be a major step in harnessing the healing power of stem cells and guiding them to areas of the body that need help.
A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
› Verified 3 days ago
Mr. Guy L. Peeples, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 604 N Spring St, Harrison, AR 72601 Phone: 870-741-6418 Fax: 870-741-5071 | |
Dr. Thomas Richard Hoberock, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3213 Hwy 392 W, Harrison, AR 72601 Phone: 870-741-7331 | |
Mr. Andrew L. Coble, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 604 N Spring Street, Harrison, AR 72601 Phone: 870-741-6418 Fax: 870-741-5071 |